In agreement with previous studies [22,41,49,50], carriers of BRCA1/2 mutations in the current study are characterized by early onset, positive family history of breast cancer, premenopausal state at diagnosis, and positive lymph node involvement. The gene discussed is BRCA1; the disease is breast cancer.